200,000+ products from a single source!

sales@angenechem.com

Home > Amines > 2450-71-7

2450-71-7

2450-71-7 | 2-Propyn-1-amine

CAS No: 2450-71-7 Catalog No: AG002OCW MDL No:MFCD00008198

Product Description

Catalog Number:
AG002OCW
Chemical Name:
2-Propyn-1-amine
CAS Number:
2450-71-7
Molecular Formula:
C3H5N
Molecular Weight:
55.0785
MDL Number:
MFCD00008198
IUPAC Name:
prop-2-yn-1-amine
InChI:
InChI=1S/C3H5N/c1-2-3-4/h1H,3-4H2
InChI Key:
JKANAVGODYYCQF-UHFFFAOYSA-N
SMILES:
NCC#C
EC Number:
219-513-8
NSC Number:
80642

Properties

Complexity:
38.5  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
55.042g/mol
Formal Charge:
0
Heavy Atom Count:
4  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
55.08g/mol
Monoisotopic Mass:
55.042g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
26A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.4  

Literature

Title Journal
Kinetic resolution of propargylamines via a highly enantioselective non-enzymatic N-acylation process. Chemical communications (Cambridge, England) 20121104
Bacitracin-conjugated superparamagnetic iron oxide nanoparticles: synthesis, characterization and antibacterial activity. Chemphyschem : a European journal of chemical physics and physical chemistry 20121008
A versatile method for functionalization and grafting of 2-hydroxyethyl cellulose (HEC) via Click chemistry. Carbohydrate polymers 20121001
Stereoselective intermolecular C-H amination reactions. Chemical communications (Cambridge, England) 20120814
Site-specific protein propargylation using tissue transglutaminase. Organic & biomolecular chemistry 20120721
Highly enantioselective synthesis of chiral allenes by sequential creation of stereogenic center and chirality transfer in a single pot operation. Organic letters 20120615
Site-specific modification of amino acids and peptides by aldehyde-alkyne-amine coupling under ambient aqueous conditions. Organic letters 20120615
Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine. European journal of medicinal chemistry 20120601
6-Bromo-2-(diprop-2-ynyl-amino)-1H-benzo[de]isoquinoline-1,3(2H)-dione. Acta crystallographica. Section E, Structure reports online 20120601
Cyclocondensation of amino-propargyl silanes. Organic letters 20120504
Gold(I)-catalyzed unprecedented rearrangement reaction between 2-aminobenzaldehydes with propargyl amines: an expedient route to 3-aminoquinolines. Chemistry (Weinheim an der Bergstrasse, Germany) 20120427
Silica based click amino stationary phase for ion chromatography and hydrophilic interaction liquid chromatography. The Analyst 20120407
Efficient iron(III)-catalyzed three-component coupling reaction of alkynes, CH2Cl2 and amines to propargylamines. Chemical communications (Cambridge, England) 20120214
Highly stereoselective synthesis of cis-β-enaminones mediated by diethyl azodicarboxylate. Chemical communications (Cambridge, England) 20120207
Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 20120101
Synthesis and properties of molecular probes for the rescue site on mutant cystic fibrosis transmembrane conductance regulator. Journal of medicinal chemistry 20111222
Site-specific labeling of DNA and RNA using an efficiently replicated and transcribed class of unnatural base pairs. Journal of the American Chemical Society 20111214
The marriage of organocatalysis with metal catalysis: access to multisubstituted chiral 2,5-dihydropyrroles by cascade iminium/enamine-metal cooperative catalysis. Chemistry (Weinheim an der Bergstrasse, Germany) 20111209
Synthesis of steroid-ferrocene conjugates of steroidal 17-carboxamides via a palladium-catalyzed aminocarbonylation--copper-catalyzed azide-alkyne cycloaddition reaction sequence. Steroids 20111101
Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline. Movement disorders : official journal of the Movement Disorder Society 20111101
Propargylaminyl 3α-hy-droxy-11-oxo-18β-olean-12-en-29-oate. Acta crystallographica. Section E, Structure reports online 20111101
Chemical synthesis of cell-permeable apoptotic peptides from in vivo produced proteins. Bioconjugate chemistry 20110921
Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease. European journal of medicinal chemistry 20110901
Propargylamine synthesis by copper-catalyzed oxidative coupling of alkynes and tertiary amine N-oxides. The Journal of organic chemistry 20110819
Gold(I) catalysts with bifunctional P, N ligands. Inorganic chemistry 20110815
Electrochemical impedance spectroscopy sensor for ascorbic acid based on copper(I) catalyzed click chemistry. Biosensors & bioelectronics 20110715
Epidermal growth factor-PEG functionalized PAMAM-pentaethylenehexamine dendron for targeted gene delivery produced by click chemistry. Biomacromolecules 20110613
Medical management of Parkinson's disease: focus on neuroprotection. Current neuropharmacology 20110601
Versatility of alkyne-modified poly(glycidyl methacrylate) layers for click reactions. Langmuir : the ACS journal of surfaces and colloids 20110517
Fluoride-cleavable, fluorescently labelled reversible terminators: synthesis and use in primer extension. Chemistry (Weinheim an der Bergstrasse, Germany) 20110301
MAO-inhibitors in Parkinson's Disease. Experimental neurobiology 20110301
Amphiphilic amylose-g-poly(meth)acrylate copolymers through 'click' onto grafting method. Biomacromolecules 20110214
Star polymers composed entirely of amino acid building blocks: a route towards stereospecific, biodegradable and hierarchically functionalized stars. Chemical communications (Cambridge, England) 20110128
Enhanced chiral recognition by cyclodextrin dimers. International journal of molecular sciences 20110101
Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease. BMC neurology 20110101
Methods for Activity Analysis of the Proteins that Regulate Histone Methylation. Current chemical genomics 20110101
Synthesis of specifically modified oligonucleotides for application in structural and functional analysis of RNA. Journal of nucleic acids 20110101
The promise of neuroprotective agents in Parkinson's disease. Frontiers in neurology 20110101
Nanomicelle with long-term circulation and enhanced stability of camptothecin based on mPEGylated alpha,beta-poly (L-aspartic acid)-camptothecin conjugate. Colloids and surfaces. B, Biointerfaces 20101101
A simple method for the preparation of propargylamines using molecular sieve modified with copper(II). Organic & biomolecular chemistry 20101021
Fine-tuning the morphology of self-assembled nanostructures of propargyl ammonium-based amphiphiles. The journal of physical chemistry. B 20101007
Merging nucleophilic and hydrogen bonding catalysis: an anion binding approach to the kinetic resolution of propargylic amines. Journal of the American Chemical Society 20101006
Highly diastereoselective synthesis of α-difluoromethyl amines from N-tert-butylsulfinyl ketimines and difluoromethyl phenyl sulfone. Chemistry (Weinheim an der Bergstrasse, Germany) 20101004
Mechanistic insights into the one-pot synthesis of propargylamines from terminal alkynes and amines in chlorinated solvents catalyzed by gold compounds and nanoparticles. Chemistry (Weinheim an der Bergstrasse, Germany) 20100809
Shell-cross-linked micelles from PNIPAM-b-(PLL)2 Y-shaped miktoarm star copolymer as drug carriers. Biomacromolecules 20100712
Unprecedented Cu(I)-catalyzed microwave-assisted three-component coupling of a ketone, an alkyne, and a primary amine. Organic letters 20100604
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents. Experimental neurobiology 20100601
New xanthate-based radical cyclization onto alkynes. Chemical communications (Cambridge, England) 20100414
Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. Journal of the American Chemical Society 20100310
Chiral N-phosphonyl imine chemistry: an efficient asymmetric synthesis of chiral N-phosphonyl propargylamines. Organic & biomolecular chemistry 20100307
Copper-catalyzed enantioselective three-component synthesis of optically active propargylamines from aldehydes, amines, and aliphatic alkynes. Chemistry (Weinheim an der Bergstrasse, Germany) 20100222
A versatile synthetic platform based on strained propargyl amines. Angewandte Chemie (International ed. in English) 20100222
TVP1022 protects neonatal rat ventricular myocytes against doxorubicin-induced functional derangements. The Journal of pharmacology and experimental therapeutics 20100201
Silver(I)-mediated highly enantioselective synthesis of axially chiral allenes under thermal and microwave-assisted conditions. Chemical communications (Cambridge, England) 20100114
Propargyl amine synthesis catalysed by gold and copper thin films by using microwave-assisted continuous-flow organic synthesis (MACOS). Chemistry (Weinheim an der Bergstrasse, Germany) 20100104
Propargylamine containing compounds as modulators of proteolytic cleavage of amyloid-beta protein precursor: involvement of MAPK and PKC activation. Journal of Alzheimer's disease : JAD 20100101
Native chemical ligation in the synthesis of internally modified oligonucleotide-peptide conjugates. Biopolymers 20100101
Highly selective fluorescent probe for Au3+ based on cyclization of propargylamide. Chemical communications (Cambridge, England) 20091214
Zn(II)-Catalyzed synthesis of piperidines from propargyl amines and cyclopropanes. Organic letters 20090820
Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease. Expert review of neurotherapeutics 20090801
Iron(III)-catalyzed and air-mediated tandem reaction of aldehydes, alkynes and amines: an efficient approach to substituted quinolines. Chemistry (Weinheim an der Bergstrasse, Germany) 20090622
Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain. Bioorganic & medicinal chemistry letters 20090615
Three-component synthesis of N-Boc-4-iodopyrroles and sequential one-pot alkynylation. Organic letters 20090604
The 'Corey's reagent,' 3,5-di-tert-butyl-1,2-benzoquinone, as a modifying agent in the synthesis of fluorescent and double-headed nucleosides. Nucleosides, nucleotides & nucleic acids 20090501
Chemoselective C-H bond activation: ligand and solvent free iron-catalyzed oxidative C-C cross-coupling of tertiary amines with terminal alkynes. Reaction scope and mechanism. Organic letters 20090416
Functionalization of macroporous organic polymer monolith based on succinimide ester reactivity for chiral capillary chromatography: a cyclodextrin click approach. Macromolecular rapid communications 20090116
Synthesis of diacetylene-containing peptide building blocks and amphiphiles, their self-assembly and topochemical polymerization in organic solvents. Chemistry (Weinheim an der Bergstrasse, Germany) 20090101
Chemicals possessing a neurotrophin-like activity on dopaminergic neurons in primary culture. PloS one 20090101
Total synthesis of pentabromo- and pentachloropseudilin, and synthetic analogues--allosteric inhibitors of myosin ATPase. Angewandte Chemie (International ed. in English) 20090101
Role of rasagiline in treating Parkinson's disease: Effect on disease progression. Therapeutics and clinical risk management 20090101
A novel feature of intramolecular vibrational redistribution in propargyl alcohol and propargyl amine. The Journal of chemical physics 20080921
TVP1022 and propargylamine protect neonatal rat ventricular myocytes against doxorubicin-induced and serum starvation-induced cardiotoxicity. Journal of cardiovascular pharmacology 20080901
Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries. Natural product reports 20080801
Clorgyline and other propargylamine derivatives as inhibitors of succinate-dependent H(2)O(2) release at NADH:UBIQUINONE oxidoreductase (Complex I) in brain mitochondria. Journal of bioenergetics and biomembranes 20080801
A new polymorph of N-(prop-2-yn-yl)tricyclo-[3.3.1.1]decane-1-carbox-amide. Acta crystallographica. Section E, Structure reports online 20080801
New hydroxypyridinone iron-chelators as potential anti-neurodegenerative drugs. Frontiers in bioscience : a journal and virtual library 20080501
Genetic findings in Parkinson's disease and translation into treatment: a leading role for mitochondria? Genes, brain, and behavior 20080301
The phosphate site of trehalose phosphorylase from Schizophyllum commune probed by site-directed mutagenesis and chemical rescue studies. The FEBS journal 20080301
Gold-catalyzed highly enantioselective synthesis of axially chiral allenes. Organic letters 20080207
Rasagiline in treatment of Parkinson's disease. Neuropsychiatric disease and treatment 20080201
Enantioselective copper-catalyzed propargylic amination. Angewandte Chemie (International ed. in English) 20080101
A highly efficient and selective Au(I)-catalyzed tandem synthesis of diversely substituted pyrrolo[1,2-a]quinolines in aqueous media. Angewandte Chemie (International ed. in English) 20080101
Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators. BMC neuroscience 20080101
Chronic experimental diabetes accelerates urinary elimination of deprenyl and its metabolites. The open medicinal chemistry journal 20080101
Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy. Annals of the New York Academy of Sciences 20071201
Diastereoselective alkynylation of N-p-tolylsulfinylimines with aluminum acetylides. The Journal of organic chemistry 20071012
One-pot synthesis of new A-ring fused steroidal pyridines. Steroids 20071001
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Clinical therapeutics 20070901
Rapid, efficient synthesis of heterobifunctional biodegradable dendrimers. Journal of the American Chemical Society 20070606
Mitochondrial nutrition as a strategy for neuroprotection in Parkinson's disease—research focus in the department of alternative medicine and experimental therapeutics at Hokuriku University. Evidence-based complementary and alternative medicine : eCAM 20070601
Rasagiline - a novel MAO B inhibitor in Parkinson's disease therapy. Therapeutics and clinical risk management 20070601
Grafting of poly[2-(tert-butylamino)ethyl methacrylate] onto polypropylene by reactive blending and antibacterial activity of the copolymer. Biomacromolecules 20070401
A clickable inhibitor reveals context-dependent autoactivation of p90 RSK. Nature chemical biology 20070301
A RSK kinase inhibitor reporting its selectivity in vivo. Nature chemical biology 20070301
Efficient ruthenium and copper cocatalzyed five-component coupling to form dipropargyl amines under mild conditions in water. Organic & biomolecular chemistry 20070207
Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease. Journal of neurochemistry 20070101
Neuroprotection by propargylamines in Parkinson's disease: intracellular mechanism underlying the anti-apoptotic function and search for clinical markers. Journal of neural transmission. Supplementum 20070101
EPR studies of amine radical cations. Part 2. Thermal and photo-induced rearrangements of propargylamine and allylamine radical cations in low-temperature freon matrices. The journal of physical chemistry. A 20061228
A new consecutive three-component oxazole synthesis by an amidation-coupling-cycloisomerization (ACCI) sequence. Chemical communications (Cambridge, England) 20061214
Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil. Neurotoxicity research 20061201
Aminopropargyl derivative of terpyridine-bis(methyl-enamine) tetraacetic acid chelate of europium (Eu (TMT)-AP3): a new reagent for fluorescent labelling of proteins and peptides. Organic & biomolecular chemistry 20061121
Direct addition of alkynes to imines and related C=N electrophiles: A convenient access to propargylamines. Chemical communications (Cambridge, England) 20061104
Solid-phase synthesis of C-terminally modified peptides. Journal of peptide science : an official publication of the European Peptide Society 20061101
Synthesis of 3-miktoarm stars and 1st generation mikto dendritic copolymers by 'living' radical polymerization and 'click' chemistry. Journal of the American Chemical Society 20060906
Asymmetric synthesis of alpha,alpha-dibranched propargylamines by acetylide additions to N-tert-butanesulfinyl ketimines. The Journal of organic chemistry 20060901
[Molecular mechanisms of the neuroprotective effect of (-)-deprenyl]. Orvosi hetilap 20060709
Microwave assisted 'click' chemistry for the synthesis of multiple labeled-carbohydrate oligonucleotides on solid support. The Journal of organic chemistry 20060609
Highly enantioselective access to primary propargylamines: 4-piperidinone as a convenient protecting group. Organic letters 20060525
Practical highly enantioselective synthesis of propargylamines through a copper-catalyzed one-pot three-component condensation reaction. Chemistry (Weinheim an der Bergstrasse, Germany) 20060524
Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease. Neurology 20060523
Rasagiline: A second-generation monoamine oxidase type-B inhibitor for the treatment of Parkinson's disease. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20060515
Zinc- and indium-promoted conjugate addition-cyclization reactions of ethenetricarboxylates with propargylamines and alcohol: novel methylenepyrrolidine and methylenetetrahydrofuran syntheses. The Journal of organic chemistry 20060428
Gold(III) Salen complex-catalyzed synthesis of propargylamines via a three-component coupling reaction. Organic letters 20060413
A mechanism-based inactivator for histone demethylase LSD1. Journal of the American Chemical Society 20060412
Antioxidant properties of propargylamine derivatives: assessment of their ability to scavenge peroxynitrite. The Journal of pharmacy and pharmacology 20060401
Synthesis of oligonucleotides with 3'-terminal 5-(3-acylamidopropargyl)-3'-amino-2',3'-dideoxyuridine residues and their reactivity in single-nucleotide steps of chemical replication. The Journal of organic chemistry 20060203
N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2. Journal of neural transmission (Vienna, Austria : 1996) 20060101
M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease. Journal of neural transmission. Supplementum 20060101
Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety. Journal of neural transmission. Supplementum 20060101
Modification of Monoaminergic Activity by MAO Inhibitors Influences Methamphetamine Actions. Drug target insights 20060101
para-Hydrogenation of unsaturated moieties on poly(lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents. Organic & biomolecular chemistry 20051107
Regulation of Bcl-2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20051101
Clinical pharmacology of rasagiline: a novel, second-generation propargylamine for the treatment of Parkinson disease. Journal of clinical pharmacology 20050801
Novel neuroprotective mechanism of action of rasagiline is associated with its propargyl moiety: interaction of Bcl-2 family members with PKC pathway. Annals of the New York Academy of Sciences 20050801
Electrostatic stabilization in a pre-organized polar active site: the catalytic role of Lys-80 in Candida tenuis xylose reductase (AKR2B5) probed by site-directed mutagenesis and functional complementation studies. The Biochemical journal 20050715
Generation of N-heterocyclic carbenes by metal-mediated coupling of propargylamine and isocyanides. Journal of the American Chemical Society 20050622
A Re(V)-catalyzed C-N bond-forming route to human lipoxygenase inhibitors. Organic letters 20050609
Neuropharmacological, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline. Drugs of today (Barcelona, Spain : 1998) 20050601
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain research. Brain research reviews 20050401
Determining the origin of the stabilization of DNA by 5-aminopropynylation of pyrimidines. Biochemistry 20050329
Synthesis of heterocyclic allenes via palladium-catalyzed hydride-transfer reaction of propargylic amines. The Journal of organic chemistry 20050318
An efficient synthesis of propargylamines via C-H activation catalyzed by copper(I) in ionic liquids. Chemical communications (Cambridge, England) 20050314
Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mechanisms of ageing and development 20050201
Rasagiline: neurodegeneration, neuroprotection, and mitochondrial permeability transition. Journal of neuroscience research 20050101
Neuroprotection by rasagiline: a new therapeutic approach to Parkinson's disease? CNS drug reviews 20050101
CGP 3466B has no effect on disease course of (G93A) mSOD1 transgenic mice. Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases 20041201
Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease. Neurology 20041012
Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases. Journal of neural transmission (Vienna, Austria : 1996) 20041001
CuBr-catalyzed efficient alkynylation of sp3 C-H bonds adjacent to a nitrogen atom. Journal of the American Chemical Society 20040929
The mechanism of nitrogenase. Computed details of the site and geometry of binding of alkyne and alkene substrates and intermediates. Journal of the American Chemical Society 20040929
Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20040901
Differential inhibition of six copper amine oxidases by a family of 4-(aryloxy)-2-butynamines: evidence for a new mode of inactivation. Biochemistry 20040831
Localization of a catalytic intermediate bound to the FeMo-cofactor of nitrogenase. The Journal of biological chemistry 20040813
Selective inhibition of bovine plasma amine oxidase by homopropargylamine, a new inactivator motif. Journal of the American Chemical Society 20040630
Helical polymer carrying helical grafts from peptide-based acetylene macromonomers: synthesis. Macromolecular bioscience 20040625
Synthesis, characterisation and molecular structure of Re(III) 2-oxacyclocarbenes stabilised by a benzoyldiazenido ligand. Dalton transactions (Cambridge, England : 2003) 20040307
Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease? BioEssays : news and reviews in molecular, cellular and developmental biology 20040101
Simultaneous analytical method for the determination of TCH346 and its four metabolites in human plasma by liquid chromatography/tandem mass spectrometry. Rapid communications in mass spectrometry : RCM 20040101
Advances in neuroprotection research for neurodegenerative diseases. Advances in experimental medicine and biology 20040101
Cytotoxicity, cytoprotection and neurotoxicity of novel deprenyl-related propargylamines, stable nitroxide free radicals, in vitro and in vivo. In vivo (Athens, Greece) 20040101
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20031201
Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity. British journal of cancer 20031117
L-Deprenyl as an inhibitor of menadione-induced permeability transition in liver mitochondria. Biochemical pharmacology 20031101
TCH346 prevents motor symptoms and loss of striatal FDOPA uptake in bilaterally MPTP-treated primates. Neurobiology of disease 20031101
Rasagiline: an anti-Parkinson drug with neuroprotective activity. Expert review of neurotherapeutics 20031101
Inhibition of bovine plasma amine oxidase by 1,4-diamino-2-butenes and -2-butynes. Bioorganic & medicinal chemistry 20031015
The essentiality of Bcl-2, PKC and proteasome-ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline. Biochemical pharmacology 20031015
Enantioselective cyclization of alkene radical cations. Organic letters 20031002
Synthesis of a high-affinity fluorescent PPARgamma ligand for high-throughput fluorescence polarization assays. Bioorganic & medicinal chemistry 20031001
Three-component enantioselective synthesis of propargylamines through Zr-catalyzed additions of alkyl zinc reagents to alkynylimines. Angewandte Chemie (International ed. in English) 20030915
Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: a new one-pot approach to functionalized pyridines. The Journal of organic chemistry 20030905
Enantioselective synthesis of propargylamines through Zr-catalyzed addition of mixed alkynylzinc reagents to arylimines. Organic letters 20030904
Synthesis of enantiomerically enriched propargylamines by copper-catalyzed addition of alkynes to enamines. Chemistry (Weinheim an der Bergstrasse, Germany) 20030616
A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease. Progress in neuro-psychopharmacology & biological psychiatry 20030601
Highly potent propargylamine and allylamine inhibitors of bovine plasma amine oxidase. Biochemical and biophysical research communications 20030516
Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor. Neuroscience letters 20030508
Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. Journal of neural transmission (Vienna, Austria : 1996) 20030501
Iterative oxazole assembly via alpha-chloroglycinates: total synthesis of (-)-muscoride A. Angewandte Chemie (International ed. in English) 20030328
Novel iminium ion equivalents prepared through C-H oxidation for the stereocontrolled synthesis of functionalized propargylic amine derivatives. Journal of the American Chemical Society 20030226
Protein 4.1N is required for translocation of inositol 1,4,5-trisphosphate receptor type 1 to the basolateral membrane domain in polarized Madin-Darby canine kidney cells. The Journal of biological chemistry 20030207
Antioxidant properties of newly synthesized N-propargylamine derivatives of nitroxyl: a comparison with deprenyl. Polish journal of pharmacology 20030101
Synthesis and energy transfer efficiency of FRET terminators derived from different linkers. Nucleosides, nucleotides & nucleic acids 20030101
Anti-apoptotic function of propargylamine inhibitors of type-B monoamine oxidase. Inflammopharmacology 20030101
Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. Journal of medicinal chemistry 20021121
Stable DNA triple helix formation using oligonucleotides containing 2'-aminoethoxy,5-propargylamino-U. Biochemistry 20020611
Enantioselective direct-addition of terminal alkynes to imines catalyzed by copper(I)pybox complex in water and in toluene. Journal of the American Chemical Society 20020522
Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. The Journal of pharmacology and experimental therapeutics 20020501
The anti-Parkinson drug, rasagiline, prevents apoptotic DNA damage induced by peroxynitrite in human dopaminergic neuroblastoma SH-SY5Y cells. Journal of neural transmission (Vienna, Austria : 1996) 20020401
Pharmacological interventions in aging and age-associated disorders: potentials of propargylamines for human use. Annals of the New York Academy of Sciences 20020401
Transition-metal-catalyzed reactions of propargylamine with carbon dioxide and carbon disulfide. The Journal of organic chemistry 20020111
The influence of metabolism on the MAO-B inhibitory potency of selegiline. Current medicinal chemistry 20020101
Aliphatic propargylamines as symptomatic and neuroprotective treatments for neurodegenerative diseases. Neurotoxicology and teratology 20020101
Neuroprotection by propargylamines in Parkinson's disease: suppression of apoptosis and induction of prosurvival genes. Neurotoxicology and teratology 20020101
Cyclization of electron-deficient cyclopentadienone with 2-alkenyl and 2-alkynylamines via sequential pericyclic reaction pathway. The Journal of organic chemistry 20011228
Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. Cellular and molecular neurobiology 20011201
Novel intramolecular rearrangement of tertiary propargylamine N-oxides. The Journal of organic chemistry 20011019
Synthesis of N-(3-arylpropyl)amino acid derivatives by Sonogashira types of reaction in aqueous media. Organic letters 20010906
Antiapoptotic properties of rasagiline, N-propargylamine-1(R)-aminoindan, and its optical (S)-isomer, TV1022. Annals of the New York Academy of Sciences 20010601
Maintaining mitochondrial membrane impermeability. an opportunity for new therapy in glaucoma? Survey of ophthalmology 20010501
Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy. Annals of the New York Academy of Sciences 20010401
Phosphoramidites and oligonucleotides containing 7-deazapurines and pyrimidines carrying aminopropargyl side chains. Nucleosides, nucleotides & nucleic acids 20010101
Novel propargylamine-linked nucleosides for high throughput SNP genotyping by MALDI-TOF MS. Nucleosides, nucleotides & nucleic acids 20010101
Mechanism-based inactivation of porcine kidney diamine oxidase by 1,4-diamino-2-butene. Biochimica et biophysica acta 19951115

© 2019 Angene International Limited. All rights Reserved.